Laparoscopic splenectomy: learning curve comparison between benign and malignant disease

Area of Science:

• Surgical innovation and patient safety
• Minimally invasive surgical techniques
• Hematologic disease management

Background:

• Formal evaluation of new surgical techniques is essential for safety and feasibility.
• This study assesses institutional experience with laparoscopic splenectomy (LS) for hematologic diseases since 1996.
• Cumulative sum (CUSUM) analysis was used to evaluate the surgeon's learning curve.

Purpose of the Study:

• To evaluate the learning curve associated with laparoscopic splenectomy (LS) for benign and malignant hematologic diseases.
• To assess the feasibility and safety of introducing LS within a surgical practice.
• To demonstrate a model for evaluating new surgical techniques.

Main Methods:

• Retrospective chart review of 123 consecutive splenectomies for hematologic disease (1996-2008).
• Primary outcome measured was conversion from laparoscopic to open splenectomy.
• CUSUM analysis was employed to analyze the LS learning curve.

Main Results:

• 58% of patients underwent planned LS, with an overall conversion rate of 21%.
• The learning curve for LS in malignant disease remained within acceptable thresholds; however, the curve for benign disease exceeded the threshold at case 29.
• No significant differences in operative time, transfusion, morbidity, or mortality were observed between benign and malignant disease groups.

Conclusions:

• Laparoscopic splenectomy for hematologic diseases is associated with a significant learning curve.
• This study highlights the importance of careful patient selection and continuous quality assessment when implementing new surgical procedures.
• The CUSUM analysis model effectively illustrates the learning process for new surgical techniques.